OWC Pharmaceutical Research Corp (OWCP)

[Hercules1]

OWC Pharmaceutical Research Corp. (OTCQB: OWCP)



engages in the research and development of Cannabis-based medical products. OWCP provides medical products for the treatment of various medical conditions and/or diseases, and provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. OWC Pharmaceutical conducts medical research and clinical trials through its wholly-owned Israeli subsidiary, One Word Cannabis Ltd., in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for multiple myeloma, psoriasis, fibromyalgia, PTSD, migraines, and of a unique delivery system.